Chicago Pacific Founders UGP III, LLC
Known title: 10% OwnerCIK: 0001975658
Chicago Pacific Founders UGP III, LLC's purchase track record
How the stock did after each of Chicago Pacific Founders UGP III, LLC's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
8
of 8 since May 15, 2023
Stock higher 6 months later
0%
3 months: 0%
Median 6-month return
-58.6%
3 months: -50.7%
Beat the S&P 500
0%
median -65.3% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/12/2024 | PIII | $82K | -57.2% | -66.0% | -1.3% |
| 9/4/2024 | PIII | $246K | -50.1% | -60.0% | +5.8% |
| 9/11/2023 | PIII | $912K | -52.7% | -56.1% | +14.1% |
| 9/1/2023 | PIII | $745K | -44.3% | -50.5% | +13.8% |
| 8/24/2023 | PIII | $897K | -16.7% | -26.7% | +16.2% |
| 5/31/2023 | PIII | $382K | -51.4% | -70.1% | +8.9% |
| 5/23/2023 | PIII | $1.57M | -59.6% | -70.5% | +9.5% |
| 5/15/2023 | PIII | $1.78M | -38.9% | -57.3% | +6.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| PIII | ▲ Buy | Open Market | 80,000 | $40K | 9/13/2024 | View on chart |
| PIII | ▲ Buy | Open Market | 80,000 | $42K | 9/12/2024 | View on chart |
| PIII | ▲ Buy | Open Market | 80,000 | $45K | 9/11/2024 | View on chart |
| PIII | ▲ Buy | Open Market | 80,000 | $41K | 9/10/2024 | View on chart |
| PIII | ▲ Buy | Open Market | 80,000 | $43K | 9/9/2024 | View on chart |
| PIII | ▲ Buy | Open Market | 80,000 | $39K | 9/6/2024 | View on chart |
| PIII | ▲ Buy | Open Market | 80,000 | $39K | 9/5/2024 | View on chart |
| PIII | ▲ Buy | Open Market | 80,000 | $39K | 9/4/2024 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $238K | 9/13/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $237K | 9/12/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $227K | 9/11/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $210K | 9/11/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $185K | 9/7/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $192K | 9/6/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $182K | 9/5/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $187K | 9/1/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $189K | 8/31/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $165K | 8/30/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $153K | 8/29/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $125K | 8/28/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $129K | 8/25/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $135K | 8/24/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 21,850 | $87K | 6/1/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 73,969 | $294K | 5/31/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 65,862 | $247K | 5/30/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $351K | 5/26/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $360K | 5/25/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 50,422 | $198K | 5/24/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 106,994 | $418K | 5/23/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 73,006 | $288K | 5/22/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $315K | 5/19/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $297K | 5/18/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $315K | 5/17/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $292K | 5/16/2023 | View on chart |
| PIII | ▲ Buy | Open Market | 90,000 | $271K | 5/15/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
PIII appoints new Chief Clinical Officer
P3 Health Partners announced the appointment of a new Chief Clinical Officer. The executive will oversee clinical operations and strategy for the company. This addition brings additional expertise as the firm pursues its growth plans. The stock is currently trading with a low RSI and near its recent support level.
PIII appoints new Chief Clinical Officer. P3 Health Partners announced the appointment of a new Chief Clinical Officer. The executive will oversee clinical operations and strategy for the company. This addition brings additional expertise as the firm pursues its growth plans. The stock is currently trading with a low RSI and near its recent support level.